By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. Its first biopharmaceutical product, NexoBrid removes dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns. NexoBrid is currently in clinical development in North America and is in the process of preparing its Biologics License Application. The company derives its revenue from United States.

Contact Information

Website: www.mediwound.com
Email: info@mediwound.com
Main Phone: +972 779714100
Address: 42 Hayarkon Street
City / Town: Yavne
Country: IL
Postal Code: 8122745

Issuer Information

Exchange: NSD
CEO: Sharon Malka
Employees: 75
NAICS: Pharmaceutical P

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A